| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0021 | 1 |